Table 1.
Clinical characteristics of control and AMI patients
| Variables | Control (n = 55) | AMI (n = 183) | P value |
|---|---|---|---|
| Male (n, %) | 33 (60.00%) | 155 (84.70%) | < 0.001 |
| Age (years) | 66.87 ± 9.45 | 63.66 ± 10.94 | 0.036 |
| BMI (kg/m2) | 23.48 ± 2.32 | 23.83 ± 2.84 | 0.349 |
| Current smoking (n, %) | 17 (30.90%) | 98 (53.55%) | 0.003 |
| Diabetes (n, %) | 8 (14.54%) | 46 (25.14%) | 0.100 |
| Hypertention (n, %) | 15 (27.27%) | 96 (52.40%) | 0.001 |
| Hyperlipidemia (n, %) | 14 (25.45%) | 55 (30.05%) | 0.510 |
| SBP on admission (mmHg) | 137.69 ± 21.78 | 128.69 ± 19.80 | 0.004 |
| DBP on admission (mmHg) | 74.34 ± 10.52 | 75.88 ± 11.85 | 0.358 |
| Glucose (mmol/L) | 5.57 ± 1.53 | 6.23 ± 2.04 | 0.012 |
| Albumin (g/L) | 40.87 ± 4.32 | 39.45 ± 4.26 | < 0.001 |
| Triglycerides (mmol/L) | 1.38 ± 0.62 | 1.52 ± 0.86 | 0.168 |
| Total cholesterol (mmol/L) | 4.22 ± 0.91 | 4.28 ± 1.00 | 0.659 |
| HDL-C (mmol/L) | 1.22 ± 0.34 | 1.05 ± 0.29 | < 0.001 |
| LDL-C (mmol/L) | 2.58 ± 0.79 | 2.77 ± 0.89 | 0.133 |
| Apo A (g/L) | 1.29 ± 0.24 | 1.15 ± 0.36 | 0.001 |
| Apo B (g/L) | 0.83 ± 0.23 | 0.92 ± 0.26 | 0.010 |
| Creatinine (umol/L) | 73.29 ± 18.83 | 81.58 ± 25.99 | 0.010 |
| Fibrinogen (g/L) | 3.35 ± 0.84 | 4.24 ± 1.23 | < 0.001 |
| D-Dimer (mg/L) | 0.3 (0.19,0.44) | 0.46 (0.30,0.79) | < 0.001 |
| CTnI (ng/mL) | 0.01 (0.00,0.01) | 5.62 (1.10,28.28) | < 0.001 |
| NT-proBNP (pg/mL) | 124 (59.00,200.00) | 690 (278.00,1855.00) | < 0.001 |
| Visfatin (ng/mL) | 6.74 (5.76,7.53) | 7.70 (6.57,9.82) | < 0.001 |